Search - tctmd.com

Displaying 481 - 500 of 1171

Sort: Relevancy | Date

Presentation TCT 2018

TCT-108: Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

Presenter: John D. Puskas, Alfredo Trento, Craig Basman

September 21, 2018

Presentation TCT 2018

TCT-107: Patient-Centered Decision-Making of Revascularization Strategy for Left Main or Multi-Vessel Coronary Artery Disease in Real-World Practice

Presenter: John D. Puskas, Alfredo Trento, Choongki Kim

September 21, 2018

Presentation TCT 2018

TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Presenter: Nicholas J. Lembo, Marie-Claude Morice, R. Jay Widmer

September 21, 2018

Presentation TCT 2018

TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Presenter: Nicholas J. Lembo, Marie-Claude Morice, Gennaro Giustino

September 21, 2018

Presentation TCT 2018

Revascularization in Cardiogenic Shock: New Insights

Presenter: Jeroen J. Bax, Stephan Windecker, Holger Thiele

September 21, 2018

Presentation TCT 2018

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Presenter: Jeroen J. Bax, Stephan Windecker, Robert A. Byrne

September 21, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News ESC 2018

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

Todd Neale

August 30, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

Ten-Year Follow-up Proves Disappointing for Bilateral Arterial Grafts in ART

Shelley Wood

August 26, 2018

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Conference News ESC 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

Todd Neale

August 25, 2018

News Daily News

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

Caitlin E. Cox

August 09, 2018

News Daily News

Acute MI Rates on the Rise Among Pregnant Women in the US

Caitlin E. Cox

July 24, 2018

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

News Industry News

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

June 18, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

Advertisement

TCT-108: Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

TCT-107: Patient-Centered Decision-Making of Revascularization Strategy for Left Main or Multi-Vessel Coronary Artery Disease in Real-World Practice

TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Revascularization in Cardiogenic Shock: New Insights

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Ten-Year Follow-up Proves Disappointing for Bilateral Arterial Grafts in ART

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

Acute MI Rates on the Rise Among Pregnant Women in the US

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content